Detection of isocitrate dehydrogenase 1 mutation R132H in myelodysplastic syndrome by mutation-specific antibody and direct sequencing

Leukemia Research

Volumn 34, Issue 8, 2010, Pages 1091-1093

  Andrulis, Mindaugas ^a   Capper, David ^a   Luft, Thomas ^b,c   Hartmann, Christian ^a,c   Zentgraf, Hanswalter ^c   von Deimling, Andreas ^a,c  

^a Institute of Pathology   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Acute myeloid leukemia; IDH1 mutation; Myelodysplastic syndrome

Indexed keywords

ISOCITRATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE 1; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; BONE MARROW BIOPSY; DNA SEQUENCE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; MYELOID PROGENITOR CELL; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BONE MARROW; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; ISOCITRATE DEHYDROGENASE; MALE; MUTATION; MYELODYSPLASTIC SYNDROMES; POLYMERASE CHAIN REACTION; PROGNOSIS;

EID: 77953611216     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.02.014     Document Type: Article

References (8)

1. Bleeker F.E., Lamba S., Leenstra S., Troost D., Hulsebos T., Vandertop W.P., et al. IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat 2009, 30(1):7-11.
2. Hartmann C., Meyer J., Balss J., Capper D., Mueller W., Christians A., et al. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol 2009, 118(4):469-474.
3. Parsons D.W., Jones S., Zhang X., Lin J.C., Leary R.J., Angenendt P., et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008, 321(5897):1807-1812.
4. Zhao S., Lin Y., Xu W., Jiang W., Zha Z., Wang P., et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 2009, 324(5924):261-265.
5. Mardis E.R., Ding L., Dooling D.J., Larson D.E., McLellan M.D., Chen K., et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009, 361(11):1058-1066.
6. Capper D., Zentgraf H., Balss J., Hartmann C., von Deimling A. Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathol 2009, 118(5):599-601.
7. Corless C.L., Harrell P., Lacouture M., Bainbridge T., Le C., Gatter K., et al. Allele-specific polymerase chain reaction for the imatinib-resistant KIT D816V and D816F mutations in mastocytosis and acute myelogenous leukemia. J Mol Diagn 2006, 8(5):604-612.
8. Capper D, Weissert S, Balss J, Habel A, Meyer J, Jäger D. Characterization of R132H mutation specific IDH1 antibody binding in brain tumors. Brain Pathol; in press 2009 Oct 27. [Epub ahead of print].